Menopause and Breast Cancer: Addressing the Secondary Health Effects of Adjuvant Chemotherapy
- 15 July 2001
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (14) , 3303-3305
- https://doi.org/10.1200/jco.2001.19.14.3303
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Ovarian Failure After Adjuvant Chemotherapy Is Associated With Rapid Bone Loss in Women With Early-Stage Breast CancerJournal of Clinical Oncology, 2001
- Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph NodesJNCI Journal of the National Cancer Institute, 2001
- Adjuvant Therapy for All Patients With Breast Cancer?JNCI Journal of the National Cancer Institute, 2001
- Lower peak bone mass and its declineBest Practice & Research Clinical Endocrinology & Metabolism, 2000
- Annual Report to the Nation on the Status of Cancer, 1973-1996, With a Special Section on Lung Cancer and Tobacco SmokingJNCI Journal of the National Cancer Institute, 1999
- Bone Mass and the Risk of Breast Cancer among Postmenopausal WomenNew England Journal of Medicine, 1997
- Bone Mineral Density and Risk of Breast Cancer in Older WomenJAMA, 1996
- Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.Journal of Clinical Oncology, 1996
- The endocrinology of the menopauseMaturitas, 1996
- Prevalence of low femoral bone density in older U.S. women from NHANES IIIJournal of Bone and Mineral Research, 1995